Ameriprise’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $82.2M | Sell |
280,900
-352,454
| -56% | -$116M | 0.02% | 633 |
|
|
2025
Q4 | $222M | Sell |
633,354
-91,684
| -13% | -$31M | 0.05% | 347 |
|
|
2025
Q3 | $234M | Sell |
725,038
-1,150,939
| -61% | -$358M | 0.05% | 334 |
|
|
2025
Q2 | $730M | Sell |
1,875,977
-67,639
| -3% | -$27.2M | 0.18% | 116 |
|
|
2025
Q1 | $845M | Buy |
1,943,616
+29,174
| +2% | +$11.7M | 0.23% | 90 |
|
|
2024
Q4 | $706M | Sell |
1,914,442
-1,872,364
| -49% | -$784M | 0.18% | 119 |
|
|
2024
Q3 | $1.97B | Sell |
3,786,806
-4,987
| -0.1% | -$2.66M | 0.51% | 28 |
|
|
2024
Q2 | $2.05B | Buy |
3,791,793
+190,118
| +5% | +$100M | 0.56% | 25 |
|
|
2024
Q1 | $1.87B | Sell |
3,601,675
-110,132
| -3% | -$54.8M | 0.51% | 32 |
|
|
2023
Q4 | $1.75B | Buy |
3,711,807
+416,803
| +13% | +$193M | 0.52% | 32 |
|
|
2023
Q3 | $1.43B | Sell |
3,295,004
-431,338
| -12% | -$196M | 0.47% | 36 |
|
|
2023
Q2 | $1.66B | Buy |
3,726,342
+103,426
| +3% | +$47.7M | 0.52% | 29 |
|
|
2023
Q1 | $1.66B | Buy |
3,622,916
+414,592
| +13% | +$197M | 0.55% | 31 |
|
|
2022
Q4 | $1.65B | Buy |
3,208,324
+171,654
| +6% | +$87.2M | 0.56% | 29 |
|
|
2022
Q3 | $1.38B | Buy |
3,036,670
+73,949
| +2% | +$35.4M | 0.51% | 31 |
|
|
2022
Q2 | $1.43B | Buy |
2,962,721
+38,645
| +1% | +$19.1M | 0.5% | 33 |
|
|
2022
Q1 | $1.43B | Buy |
2,924,076
+444,636
| +18% | +$203M | 0.42% | 43 |
|
|
2021
Q4 | $1.14B | Buy |
2,479,440
+1,046,077
| +73% | +$440M | 0.32% | 59 |
|
|
2021
Q3 | $534M | Buy |
1,433,363
+665,454
| +87% | +$253M | 0.17% | 122 |
|
|
2021
Q2 | $293M | Sell |
767,909
-65,019
| -8% | -$24.8M | 0.09% | 234 |
|
|
2021
Q1 | $299M | Sell |
832,928
-37,014
| -4% | -$11.9M | 0.1% | 209 |
|
|
2020
Q4 | $279M | Sell |
869,942
-246,365
| -22% | -$75.6M | 0.1% | 215 |
|
|
2020
Q3 | $300M | Sell |
1,116,307
-9,803
| -0.9% | -$2.64M | 0.12% | 182 |
|
|
2020
Q2 | $296M | Buy |
1,126,110
+192,190
| +21% | +$51.3M | 0.13% | 176 |
|
|
2020
Q1 | $212M | Buy |
933,920
+15,246
| +2% | +$4.15M | 0.11% | 194 |
|
|
2019
Q4 | $277M | Buy |
918,674
+136,875
| +18% | +$37.7M | 0.12% | 183 |
|
|
2019
Q3 | $188M | Sell |
781,799
-511,980
| -40% | -$140M | 0.08% | 245 |
|
|
2019
Q2 | $365M | Buy |
1,293,779
+363,296
| +39% | +$99.2M | 0.16% | 125 |
|
|
2019
Q1 | $267M | Sell |
930,483
-579,502
| -38% | -$168M | 0.12% | 185 |
|
|
2018
Q4 | $397M | Sell |
1,509,985
-210,653
| -12% | -$57.9M | 0.2% | 98 |
|
|
2018
Q3 | $536M | Sell |
1,720,638
-156,097
| -8% | -$40.5M | 0.19% | 114 |
|
|
2018
Q2 | $447M | Buy |
1,876,735
+698,043
| +59% | +$162M | 0.2% | 106 |
|
|
2018
Q1 | $259M | Buy |
1,178,692
+108,143
| +10% | +$25.4M | 0.12% | 190 |
|
|
2017
Q4 | $241M | Sell |
1,070,549
-236,776
| -18% | -$50.4M | 0.11% | 195 |
|
|
2017
Q3 | $248M | Sell |
1,307,325
-519,521
| -28% | -$98.9M | 0.12% | 190 |
|
|
2017
Q2 | $344M | Sell |
1,826,846
-176,956
| -9% | -$31.8M | 0.17% | 132 |
|
|
2017
Q1 | $331M | Sell |
2,003,802
-13,278
| -0.7% | -$2.11M | 0.17% | 133 |
|
|
2016
Q4 | $290M | Sell |
2,017,080
-578,002
| -22% | -$77.4M | 0.16% | 138 |
|
|
2016
Q3 | $325M | Buy |
2,595,082
+952,252
| +58% | +$123M | 0.18% | 117 |
|
|
2016
Q2 | $216M | Buy |
1,642,830
+1,458,880
| +793% | +$200M | 0.13% | 174 |
|
|
2016
Q1 | $25.8M | Sell |
183,950
-64,166
| -26% | -$8.57M | 0.02% | 782 |
|
|
2015
Q4 | $34.6M | Sell |
248,116
-430,488
| -63% | -$59.3M | 0.02% | 618 |
|
|
2015
Q3 | $95M | Sell |
678,604
-1,465,023
| -68% | -$220M | 0.06% | 300 |
|
|
2015
Q2 | $352M | Sell |
2,143,627
-75,819
| -3% | -$12.1M | 0.2% | 111 |
|
|
2015
Q1 | $343M | Sell |
2,219,446
-280,405
| -11% | -$39.9M | 0.2% | 114 |
|
|
2014
Q4 | $314M | Buy |
2,499,851
+97,346
| +4% | +$12M | 0.18% | 132 |
|
|
2014
Q3 | $287M | Sell |
2,402,505
-80,762
| -3% | -$9.26M | 0.17% | 143 |
|
|
2014
Q2 | $267M | Buy |
2,483,267
+450,037
| +22% | +$46.4M | 0.16% | 152 |
|
|
2014
Q1 | $202M | Buy |
2,033,230
+414,379
| +26% | +$37.5M | 0.12% | 187 |
|
|
2013
Q4 | $150M | Buy |
1,618,851
+1,305,590
| +417% | +$116M | 0.09% | 239 |
|
|
2013
Q3 | $26.2M | Buy |
313,261
+91,061
| +41% | +$7.8M | 0.02% | 850 |
|
|
2013
Q2 | $18.2M | Buy |
+222,200
| New | +$16.6M | 0.01% | 1031 |
|
Other funds holding ELV
VCM
VPM
Ameriprise's ELV Position: Q1 2026 in Review
Ameriprise reduced its Elevance Health (ELV) stake by 56% in Q1 2026, selling an estimated $116M and leaving 280,900 shares worth $82.2M. The position accounts for 0.02% of the portfolio, ranked #633.
Ameriprise first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.05B in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Ameriprise held 280,900 shares of Elevance Health worth $82.2M as of Q1 2026.
- Ameriprise sold 352,454 Elevance Health shares in Q1 2026, an estimated $116M.
- Elevance Health made up 0.02% of Ameriprise's portfolio in Q1 2026, its #633 holding.
- Ameriprise first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Elevance Health position peaked at $2.05B in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.